Table 4. Changes in both drug utilization and total inpatient cost per inpatient episode for advanced NSCLC patients after drug price cut.
| Regimen | Drug cost (RMB, mean ± SD) | P value | Total inpatient cost (RMB, mean ± SD) | P value | ||||
|---|---|---|---|---|---|---|---|---|
| Before June, 2006 | After June, 2006 | Changes (%) | Before June, 2006 | After June, 2006 | Changes (%) | |||
| NP | 5,955.12±2,308.14 | 3,556.04±803.97 | −40.29 | <0.001 | 7,815.42±2,934.38 | 5,345.01±1,494.64 | −31.61 | <0.001 |
| DC | 6,972.82±2,635.83 | 5,822.31±1,700.81 | −16.50 | 0.007 | 8,324.73±2,976.17 | 8,583.71±7,704.62 | 3.11 | 0.915 |
| GC | 7,600.71±1,852.48 | 7,959.04±2,213.61 | 4.71 | 0.699 | 9,060.92±1,975.04 | 10,737.54±.3,133.66 | 18.43 | 0.200 |
| TP | 8,440.74±1,883.73 | 9,337.61±4,999.31 | 10.63 | 0.717 | 9,666.94±2,238.03 | 12,831.07±8,731.45 | 32.73 | 0.348 |
| All regimens | 6,787.83±2,465.53 | 6,278.50 ±2,528.29 | −8.10 | 0.714 | 8,669.43±2,821.47 | 8,870.86±5,697.99 | 23.23 | 0.217 |
NSCLC, non-small cell lung cancer; SD, standard deviation; NRCMS, new rural cooperative medical scheme; URBMI, urban resident basic medical insurance; UEBMI: urban employee basic medical insurance; PFFMC, publicly funded free medical care; PFPF, payment from personal funds; NA: those whose payment information was unavailable. RMB at an exchange rate of 6.66 to US$ 1 on Aug, 2016.